Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Rounge TB, Paulsen J(2025) Highly sensitive method captures rare RNAs in blood to search for disease Nature(in press) DOI 10.1038/d41586-025-01127-7, PubMed 40240820
Moosavi SH, Kryeziu K, Eilertsen IA, Nunes L, Hektoen M, Niederdorfer B, Reims HM, Syversveen T, Grut H, Dueland S, Line PD, Lothe RA, Sveen A(2025) Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancer Br J Surg, 112(4) DOI 10.1093/bjs/znaf072, PubMed 40235343
Aune D, Nordsletten M, Myklebust TÅ, Robsahm TE, Skålhegg BS, Mala T, Yaqub S, Saeed U(2025) Body mass index and risk of Hodgkin's lymphoma: Insights from a Norwegian cohort study Eur J Cancer, 221, 115400(in press) DOI 10.1016/j.ejca.2025.115400, PubMed 40228428